APO RESEARCH · REPORT
Viral Vectors and Plasmid DNA Manufacturing
The viral vectors and plasmid DNA is used for the treatment of cancers, inherited disorders, viral infections and other diseases.
Product & engineering
Understand the product.
The viral vectors and plasmid DNA is used for the treatment of cancers, inherited disorders, viral infections and other diseases.
Selected research
Market Structure
Global Viral Vectors and Plasmid DNA Manufacturing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The viral vectors and plasmid DNA is used for the treatment of cancers, inherited disorders, viral infections and other diseases.
Global Viral Vectors and Plasmid DNA Manufacturing key players include BioReliance, Oxford BioMedica, UniQure, Cobra Biologics, etc. Global top four manufacturers hold a share over 45%.
North America is the largest market, with a share about 50%, followed by Asia-Pacific, and Europe, both have a share over 40 percent.
Read the full market overview
In terms of product, Viral Vectors is the largest segment, with a share about 80%. And in terms of application, the largest application is Cancers, followed by Inherited Disorders, Viral Infections , etc.
Report Includes
This report provides an overview of the global Viral Vectors and Plasmid DNA Manufacturing market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Viral Vectors and Plasmid DNA Manufacturing and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Viral Vectors and Plasmid DNA Manufacturing revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Viral Vectors and Plasmid DNA Manufacturing market size, projected growth trends, production technologies, key applications, and end-use industries.
Viral Vectors and Plasmid DNA Manufacturing Segment by Company
BioReliance
Cobra Biologics
Oxford BioMedica
UniQure
FinVector
MolMed
MassBiologics
Richter-Helm
FUJIFILM Diosynth Biotechnologies
Lonza
Aldevron
Eurogentec
Cell and Gene Therapy Catapult
Biovian
Thermo Fisher Scientific (Brammer Bio)
VGXI
PlasmidFactory
Viral Vectors and Plasmid DNA Manufacturing Segment by Type
Plasmid DNA
Viral Vectors
Viral Vectors and Plasmid DNA Manufacturing Segment by Application
Cancers
Inherited Disorders
Viral Infections
Others
Viral Vectors and Plasmid DNA Manufacturing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Viral Vectors and Plasmid DNA Manufacturing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Viral Vectors and Plasmid DNA Manufacturing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Viral Vectors and Plasmid DNA Manufacturing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Viral Vectors and Plasmid DNA Manufacturing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Viral Vectors and Plasmid DNA Manufacturing industry.
Chapter 3: Detailed analysis of Viral Vectors and Plasmid DNA Manufacturing companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Viral Vectors and Plasmid DNA Manufacturingrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
List of Tables
Table 1. Global Viral Vectors and Plasmid DNA Manufacturing Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032
Table 2. Key Players of Plasmid DNA
Table 3. Key Players of Viral Vectors
Table 4. Global Viral Vectors and Plasmid DNA Manufacturing Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032
Table 5. Key Players of Cancers
Table 6. Key Players of Inherited Disorders
Table 7. Key Players of Viral Infections
Table 8. Key Players of Others
Table 9. Global Viral Vectors and Plasmid DNA Manufacturing Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032
Table 10. Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Region (2021-2026) & (US$ Million)
Table 11. Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Region (2021-2026)
Table 12. Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Region (2027-2032) & (US$ Million)
Table 13. Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Region (2027-2032)
Table 14. Viral Vectors and Plasmid DNA Manufacturing Industry Trends
Table 15. Viral Vectors and Plasmid DNA Manufacturing Industry Drivers
Table 16. Viral Vectors and Plasmid DNA Manufacturing Industry Opportunities and Challenges
Table 17. Viral Vectors and Plasmid DNA Manufacturing Industry Restraints
Table 18. Global Viral Vectors and Plasmid DNA Manufacturing Revenue by Company (US$ Million) & (2021-2026)
Table 19. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Company (2021-2026)
Table 20. Global Viral Vectors and Plasmid DNA Manufacturing Players Revenue Ranking, 2024 VS 2025 VS 2026
Table 21. Global Viral Vectors and Plasmid DNA Manufacturing Key Company Head Office and Area Served
Table 22. Global Viral Vectors and Plasmid DNA Manufacturing Company, Product Type & Application
Table 23. Global Viral Vectors and Plasmid DNA Manufacturing Company Establishment Date
Table 24. Global Company Market Concentration Ratio (CR5 and HHI)
Table 25. Global Viral Vectors and Plasmid DNA Manufacturing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025)
Table 26. Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Type 2021 VS 2025 VS 2032 (US$ Million)
Table 27. Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2021-2026) & (US$ Million)
Table 28. Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2027-2032) & (US$ Million)
Table 29. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Type (2021-2026)
Table 30. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Type (2027-2032)
Table 31. Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Application 2021 VS 2025 VS 2032 (US$ Million)
Table 32. Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2021-2026) & (US$ Million)
Table 33. Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2027-2032) & (US$ Million)
Table 34. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Application (2021-2026)
Table 35. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Application (2027-2032)
Table 36. BioReliance Company Information
Table 37. BioReliance Business Overview
Table 38. BioReliance Viral Vectors and Plasmid DNA Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 39. BioReliance Viral Vectors and Plasmid DNA Manufacturing Product Portfolio
Table 40. BioReliance Recent Development
Table 41. Cobra Biologics Company Information
Table 42. Cobra Biologics Business Overview
Table 43. Cobra Biologics Viral Vectors and Plasmid DNA Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 44. Cobra Biologics Viral Vectors and Plasmid DNA Manufacturing Product Portfolio
Table 45. Cobra Biologics Recent Development
Table 46. Oxford BioMedica Company Information
Table 47. Oxford BioMedica Business Overview
Table 48. Oxford BioMedica Viral Vectors and Plasmid DNA Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 49. Oxford BioMedica Viral Vectors and Plasmid DNA Manufacturing Product Portfolio
Table 50. Oxford BioMedica Recent Development
Table 51. UniQure Company Information
Table 52. UniQure Business Overview
Table 53. UniQure Viral Vectors and Plasmid DNA Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 54. UniQure Viral Vectors and Plasmid DNA Manufacturing Product Portfolio
Table 55. UniQure Recent Development
Table 56. FinVector Company Information
Table 57. FinVector Business Overview
Table 58. FinVector Viral Vectors and Plasmid DNA Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 59. FinVector Viral Vectors and Plasmid DNA Manufacturing Product Portfolio
Table 60. FinVector Recent Development
Table 61. MolMed Company Information
Table 62. MolMed Business Overview
Table 63. MolMed Viral Vectors and Plasmid DNA Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 64. MolMed Viral Vectors and Plasmid DNA Manufacturing Product Portfolio
Table 65. MolMed Recent Development
Table 66. MassBiologics Company Information
Table 67. MassBiologics Business Overview
Table 68. MassBiologics Viral Vectors and Plasmid DNA Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 69. MassBiologics Viral Vectors and Plasmid DNA Manufacturing Product Portfolio
Table 70. MassBiologics Recent Development
Table 71. Richter-Helm Company Information
Table 72. Richter-Helm Business Overview
Table 73. Richter-Helm Viral Vectors and Plasmid DNA Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 74. Richter-Helm Viral Vectors and Plasmid DNA Manufacturing Product Portfolio
Table 75. Richter-Helm Recent Development
Table 76. FUJIFILM Diosynth Biotechnologies Company Information
Table 77. FUJIFILM Diosynth Biotechnologies Business Overview
Table 78. FUJIFILM Diosynth Biotechnologies Viral Vectors and Plasmid DNA Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 79. FUJIFILM Diosynth Biotechnologies Viral Vectors and Plasmid DNA Manufacturing Product Portfolio
Table 80. FUJIFILM Diosynth Biotechnologies Recent Development
Table 81. Lonza Company Information
Table 82. Lonza Business Overview
Table 83. Lonza Viral Vectors and Plasmid DNA Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 84. Lonza Viral Vectors and Plasmid DNA Manufacturing Product Portfolio
Table 85. Lonza Recent Development
Table 86. Aldevron Company Information
Table 87. Aldevron Business Overview
Table 88. Aldevron Viral Vectors and Plasmid DNA Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 89. Aldevron Viral Vectors and Plasmid DNA Manufacturing Product Portfolio
Table 90. Aldevron Recent Development
Table 91. Eurogentec Company Information
Table 92. Eurogentec Business Overview
Table 93. Eurogentec Viral Vectors and Plasmid DNA Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 94. Eurogentec Viral Vectors and Plasmid DNA Manufacturing Product Portfolio
Table 95. Eurogentec Recent Development
Table 96. Cell and Gene Therapy Catapult Company Information
Table 97. Cell and Gene Therapy Catapult Business Overview
Table 98. Cell and Gene Therapy Catapult Viral Vectors and Plasmid DNA Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 99. Cell and Gene Therapy Catapult Viral Vectors and Plasmid DNA Manufacturing Product Portfolio
Table 100. Cell and Gene Therapy Catapult Recent Development
Table 101. Biovian Company Information
Table 102. Biovian Business Overview
Table 103. Biovian Viral Vectors and Plasmid DNA Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 104. Biovian Viral Vectors and Plasmid DNA Manufacturing Product Portfolio
Table 105. Biovian Recent Development
Table 106. Thermo Fisher Scientific (Brammer Bio) Company Information
Table 107. Thermo Fisher Scientific (Brammer Bio) Business Overview
Table 108. Thermo Fisher Scientific (Brammer Bio) Viral Vectors and Plasmid DNA Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 109. Thermo Fisher Scientific (Brammer Bio) Viral Vectors and Plasmid DNA Manufacturing Product Portfolio
Table 110. Thermo Fisher Scientific (Brammer Bio) Recent Development
Table 111. VGXI Company Information
Table 112. VGXI Business Overview
Table 113. VGXI Viral Vectors and Plasmid DNA Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 114. VGXI Viral Vectors and Plasmid DNA Manufacturing Product Portfolio
Table 115. VGXI Recent Development
Table 116. PlasmidFactory Company Information
Table 117. PlasmidFactory Business Overview
Table 118. PlasmidFactory Viral Vectors and Plasmid DNA Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 119. PlasmidFactory Viral Vectors and Plasmid DNA Manufacturing Product Portfolio
Table 120. PlasmidFactory Recent Development
Table 121. North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2021-2026) & (US$ Million)
Table 122. North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2027-2032) & (US$ Million)
Table 123. North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2021-2026) & (US$ Million)
Table 124. North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2027-2032) & (US$ Million)
Table 125. North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million)
Table 126. North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2021-2026)
Table 127. North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2027-2032)
Table 128. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2021-2026) & (US$ Million)
Table 129. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2027-2032) & (US$ Million)
Table 130. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2021-2026) & (US$ Million)
Table 131. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2027-2032) & (US$ Million)
Table 132. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million)
Table 133. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2021-2026)
Table 134. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2027-2032)
Table 135. China Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2021-2026) & (US$ Million)
Table 136. China Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2027-2032) & (US$ Million)
Table 137. China Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2021-2026) & (US$ Million)
Table 138. China Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2027-2032) & (US$ Million)
Table 139. Asia Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2021-2026) & (US$ Million)
Table 140. Asia Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2027-2032) & (US$ Million)
Table 141. Asia Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2021-2026) & (US$ Million)
Table 142. Asia Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2027-2032) & (US$ Million)
Table 143. Asia Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million)
Table 144. Asia Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2021-2026)
Table 145. Asia Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2027-2032)
Table 146. South America, Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2021-2026) & (US$ Million)
Table 147. South America, Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2027-2032) & (US$ Million)
Table 148. South America, Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2021-2026) & (US$ Million)
Table 149. South America, Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2027-2032) & (US$ Million)
Table 150. South America, Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million)
Table 151. South America, Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2021-2026)
Table 152. South America, Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2027-2032)
Table 153. Research Programs/Design for This Report
Table 154. Authors List of This Report
Table 155. Secondary Sources
Table 156. Primary Sources
List of Figures
Figure 1. Viral Vectors and Plasmid DNA Manufacturing Product Image
Figure 2. Global Viral Vectors and Plasmid DNA Manufacturing Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million)
Figure 3. Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Type: 2025 VS 2032
Figure 4. Plasmid DNA Image
Figure 5. Viral Vectors Image
Figure 6. Global Viral Vectors and Plasmid DNA Manufacturing Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million)
Figure 7. Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Application: 2025 VS 2032
Figure 8. Cancers Image
Figure 9. Inherited Disorders Image
Figure 10. Viral Infections Image
Figure 11. Others Image
Figure 12. Global Viral Vectors and Plasmid DNA Manufacturing Market Size (US$ Million), 2021 VS 2025 VS 2032
Figure 13. Global Viral Vectors and Plasmid DNA Manufacturing Market Size (2021-2032) & (US$ Million)
Figure 14. Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Region: 2025 VS 2032
Figure 15. Years Considered
Figure 16. Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Players in 2025
Figure 17. Global Top 5 and 10 Viral Vectors and Plasmid DNA Manufacturing Players Market Share by Revenue in 2025
Figure 18. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 19. Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million)
Figure 20. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Type (2021-2032)
Figure 21. Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million)
Figure 22. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Application (2021-2032)
Figure 23. North America Viral Vectors and Plasmid DNA Manufacturing Market Size (2021-2032) & (US$ Million)
Figure 24. North America Viral Vectors and Plasmid DNA Manufacturing Market Share by Type (2021-2032)
Figure 25. North America Viral Vectors and Plasmid DNA Manufacturing Market Share by Application (2021-2032)
Figure 26. North America Viral Vectors and Plasmid DNA Manufacturing Market Share by Country (2021-2032)
Figure 27. United States Viral Vectors and Plasmid DNA Manufacturing Market Size (2021-2032) & (US$ Million)
Figure 28. Canada Viral Vectors and Plasmid DNA Manufacturing Market Size (2021-2032) & (US$ Million)
Figure 29. Mexico Viral Vectors and Plasmid DNA Manufacturing Market Size (2021-2032) & (US$ Million)
Figure 30. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size (2021-2032) & (US$ Million)
Figure 31. Europe Viral Vectors and Plasmid DNA Manufacturing Market Share by Type (2021-2032)
Figure 32. Europe Viral Vectors and Plasmid DNA Manufacturing Market Share by Application (2021-2032)
Figure 33. Europe Viral Vectors and Plasmid DNA Manufacturing Market Share by Country (2021-2032)
Figure 34. Germany Viral Vectors and Plasmid DNA Manufacturing Market Size (2021-2032) & (US$ Million)
Figure 35. France Viral Vectors and Plasmid DNA Manufacturing Market Size (2021-2032) & (US$ Million)
Figure 36. U.K. Viral Vectors and Plasmid DNA Manufacturing Market Size (2021-2032) & (US$ Million)
Figure 37. Italy Viral Vectors and Plasmid DNA Manufacturing Market Size (2021-2032) & (US$ Million)
Figure 38. Russia Viral Vectors and Plasmid DNA Manufacturing Market Size (2021-2032) & (US$ Million)
Figure 39. Nordic Countries Viral Vectors and Plasmid DNA Manufacturing Market Size (2021-2032) & (US$ Million)
Figure 40. China Viral Vectors and Plasmid DNA Manufacturing Market Size (2021-2032) & (US$ Million)
Figure 41. China Viral Vectors and Plasmid DNA Manufacturing Market Share by Type (2021-2032)
Figure 42. China Viral Vectors and Plasmid DNA Manufacturing Market Share by Application (2021-2032)
Figure 43. Asia Viral Vectors and Plasmid DNA Manufacturing Market Size (2021-2032) & (US$ Million)
Figure 44. Asia Viral Vectors and Plasmid DNA Manufacturing Market Share by Type (2021-2032)
Figure 45. Asia Viral Vectors and Plasmid DNA Manufacturing Market Share by Application (2021-2032)
Figure 46. Asia Viral Vectors and Plasmid DNA Manufacturing Market Share by Country (2021-2032)
Figure 47. Japan Viral Vectors and Plasmid DNA Manufacturing Market Size (2021-2032) & (US$ Million)
Figure 48. South Korea Viral Vectors and Plasmid DNA Manufacturing Market Size (2021-2032) & (US$ Million)
Figure 49. Taiwan Viral Vectors and Plasmid DNA Manufacturing Market Size (2021-2032) & (US$ Million)
Figure 50. Southeast Asia Viral Vectors and Plasmid DNA Manufacturing Market Size (2021-2032) & (US$ Million)
Figure 51. India Viral Vectors and Plasmid DNA Manufacturing Market Size (2021-2032) & (US$ Million)
Figure 52. Australia Viral Vectors and Plasmid DNA Manufacturing Market Size (2021-2032) & (US$ Million)
Figure 53. South America, Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size (2021-2032) & (US$ Million)
Figure 54. South America, Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Share by Type (2021-2032)
Figure 55. South America, Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Share by Application (2021-2032)
Figure 56. South America, Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Share by Country (2021-2032)
Figure 57. Brazil Viral Vectors and Plasmid DNA Manufacturing Market Size (2021-2032) & (US$ Million)
Figure 58. South Africa Viral Vectors and Plasmid DNA Manufacturing Market Size (2021-2032) & (US$ Million)
Figure 59. Saudi Arabia Viral Vectors and Plasmid DNA Manufacturing Market Size (2021-2032) & (US$ Million)
Figure 60. Turkey Viral Vectors and Plasmid DNA Manufacturing Market Size (2021-2032) & (US$ Million)
Figure 61. Argentina Viral Vectors and Plasmid DNA Manufacturing Market Size (2021-2032) & (US$ Million)
Figure 62. UAE Viral Vectors and Plasmid DNA Manufacturing Market Size (2021-2032) & (US$ Million)
Figure 63. Egypt Viral Vectors and Plasmid DNA Manufacturing Market Size (2021-2032) & (US$ Million)
Figure 64. Chile Viral Vectors and Plasmid DNA Manufacturing Market Size (2021-2032) & (US$ Million)
Figure 65. Research Process
Figure 66. Key Executives Interviewed
Scope & coverage.
Types
- Plasmid DNA
- Viral Vectors
Applications
- Cancers
- Inherited Disorders
- Viral Infections
- Others
Companies covered
- BioReliance
- Cobra Biologics
- Oxford BioMedica
- UniQure
- FinVector
- MolMed
- MassBiologics
- Richter-Helm
- FUJIFILM Diosynth Biotechnologies
- Lonza
- Aldevron
- Eurogentec
- Cell and Gene Therapy Catapult
- Biovian
- Thermo Fisher Scientific (Brammer Bio)
- VGXI
- PlasmidFactory
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Plasmid DNA
- 1.2.3 Viral Vectors
- 1.3 Market Analysis by Application
- 1.3.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Cancers
- 1.3.3 Inherited Disorders
- 1.3.4 Viral Infections
- 1.3.5 Others
- 1.4 Global Market Growth Prospects
- 1.5 Global Viral Vectors and Plasmid DNA Manufacturing Growth Trends by Region
- 1.5.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Viral Vectors and Plasmid DNA Manufacturing Market Size by Region (2021-2026)
- 1.5.3 Viral Vectors and Plasmid DNA Manufacturing Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Viral Vectors and Plasmid DNA Manufacturing Market Dynamics
- 2.1 Viral Vectors and Plasmid DNA Manufacturing Industry Trends
- 2.2 Viral Vectors and Plasmid DNA Manufacturing Industry Drivers
- 2.3 Viral Vectors and Plasmid DNA Manufacturing Industry Opportunities and Challenges
- 2.4 Viral Vectors and Plasmid DNA Manufacturing Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Viral Vectors and Plasmid DNA Manufacturing Revenue by Company (2021-2026)
- 3.2 Global Viral Vectors and Plasmid DNA Manufacturing Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Viral Vectors and Plasmid DNA Manufacturing Key Company Head office and Area Served
- 3.4 Global Viral Vectors and Plasmid DNA Manufacturing Company, Product Type & Application
- 3.5 Global Viral Vectors and Plasmid DNA Manufacturing Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Viral Vectors and Plasmid DNA Manufacturing Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Viral Vectors and Plasmid DNA Manufacturing Players Market Share by Revenue in 2025
- 3.6.3 2025 Viral Vectors and Plasmid DNA Manufacturing Tier 1, Tier 2, and Tier 3
4 Viral Vectors and Plasmid DNA Manufacturing Market by Type
- 4.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2021-2032)
- 4.3 Global Viral Vectors and Plasmid DNA Manufacturing Market Size Share by Type (2021-2032)
5 Viral Vectors and Plasmid DNA Manufacturing Market by Application
- 5.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2021-2032)
- 5.3 Global Viral Vectors and Plasmid DNA Manufacturing Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 BioReliance
- 6.1.1 BioReliance Company Information
- 6.1.2 BioReliance Business Overview
- 6.1.3 BioReliance Viral Vectors and Plasmid DNA Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 BioReliance Viral Vectors and Plasmid DNA Manufacturing Product Portfolio
- 6.1.5 BioReliance Recent Developments
- 6.2 Cobra Biologics
- 6.2.1 Cobra Biologics Company Information
- 6.2.2 Cobra Biologics Business Overview
- 6.2.3 Cobra Biologics Viral Vectors and Plasmid DNA Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Cobra Biologics Viral Vectors and Plasmid DNA Manufacturing Product Portfolio
- 6.2.5 Cobra Biologics Recent Developments
- 6.3 Oxford BioMedica
- 6.3.1 Oxford BioMedica Company Information
- 6.3.2 Oxford BioMedica Business Overview
- 6.3.3 Oxford BioMedica Viral Vectors and Plasmid DNA Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Oxford BioMedica Viral Vectors and Plasmid DNA Manufacturing Product Portfolio
- 6.3.5 Oxford BioMedica Recent Developments
- 6.4 UniQure
- 6.4.1 UniQure Company Information
- 6.4.2 UniQure Business Overview
- 6.4.3 UniQure Viral Vectors and Plasmid DNA Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 UniQure Viral Vectors and Plasmid DNA Manufacturing Product Portfolio
- 6.4.5 UniQure Recent Developments
- 6.5 FinVector
- 6.5.1 FinVector Company Information
- 6.5.2 FinVector Business Overview
- 6.5.3 FinVector Viral Vectors and Plasmid DNA Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 FinVector Viral Vectors and Plasmid DNA Manufacturing Product Portfolio
- 6.5.5 FinVector Recent Developments
- 6.6 MolMed
- 6.6.1 MolMed Company Information
- 6.6.2 MolMed Business Overview
- 6.6.3 MolMed Viral Vectors and Plasmid DNA Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 MolMed Viral Vectors and Plasmid DNA Manufacturing Product Portfolio
- 6.6.5 MolMed Recent Developments
- 6.7 MassBiologics
- 6.7.1 MassBiologics Company Information
- 6.7.2 MassBiologics Business Overview
- 6.7.3 MassBiologics Viral Vectors and Plasmid DNA Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 MassBiologics Viral Vectors and Plasmid DNA Manufacturing Product Portfolio
- 6.7.5 MassBiologics Recent Developments
- 6.8 Richter-Helm
- 6.8.1 Richter-Helm Company Information
- 6.8.2 Richter-Helm Business Overview
- 6.8.3 Richter-Helm Viral Vectors and Plasmid DNA Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Richter-Helm Viral Vectors and Plasmid DNA Manufacturing Product Portfolio
- 6.8.5 Richter-Helm Recent Developments
- 6.9 FUJIFILM Diosynth Biotechnologies
- 6.9.1 FUJIFILM Diosynth Biotechnologies Company Information
- 6.9.2 FUJIFILM Diosynth Biotechnologies Business Overview
- 6.9.3 FUJIFILM Diosynth Biotechnologies Viral Vectors and Plasmid DNA Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 FUJIFILM Diosynth Biotechnologies Viral Vectors and Plasmid DNA Manufacturing Product Portfolio
- 6.9.5 FUJIFILM Diosynth Biotechnologies Recent Developments
- 6.10 Lonza
- 6.10.1 Lonza Company Information
- 6.10.2 Lonza Business Overview
- 6.10.3 Lonza Viral Vectors and Plasmid DNA Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Lonza Viral Vectors and Plasmid DNA Manufacturing Product Portfolio
- 6.10.5 Lonza Recent Developments
- 6.11 Aldevron
- 6.11.1 Aldevron Company Information
- 6.11.2 Aldevron Business Overview
- 6.11.3 Aldevron Viral Vectors and Plasmid DNA Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Aldevron Viral Vectors and Plasmid DNA Manufacturing Product Portfolio
- 6.11.5 Aldevron Recent Developments
- 6.12 Eurogentec
- 6.12.1 Eurogentec Company Information
- 6.12.2 Eurogentec Business Overview
- 6.12.3 Eurogentec Viral Vectors and Plasmid DNA Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Eurogentec Viral Vectors and Plasmid DNA Manufacturing Product Portfolio
- 6.12.5 Eurogentec Recent Developments
- 6.13 Cell and Gene Therapy Catapult
- 6.13.1 Cell and Gene Therapy Catapult Company Information
- 6.13.2 Cell and Gene Therapy Catapult Business Overview
- 6.13.3 Cell and Gene Therapy Catapult Viral Vectors and Plasmid DNA Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 Cell and Gene Therapy Catapult Viral Vectors and Plasmid DNA Manufacturing Product Portfolio
- 6.13.5 Cell and Gene Therapy Catapult Recent Developments
- 6.14 Biovian
- 6.14.1 Biovian Company Information
- 6.14.2 Biovian Business Overview
- 6.14.3 Biovian Viral Vectors and Plasmid DNA Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 Biovian Viral Vectors and Plasmid DNA Manufacturing Product Portfolio
- 6.14.5 Biovian Recent Developments
- 6.15 Thermo Fisher Scientific (Brammer Bio)
- 6.15.1 Thermo Fisher Scientific (Brammer Bio) Company Information
- 6.15.2 Thermo Fisher Scientific (Brammer Bio) Business Overview
- 6.15.3 Thermo Fisher Scientific (Brammer Bio) Viral Vectors and Plasmid DNA Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.15.4 Thermo Fisher Scientific (Brammer Bio) Viral Vectors and Plasmid DNA Manufacturing Product Portfolio
- 6.15.5 Thermo Fisher Scientific (Brammer Bio) Recent Developments
- 6.16 VGXI
- 6.16.1 VGXI Company Information
- 6.16.2 VGXI Business Overview
- 6.16.3 VGXI Viral Vectors and Plasmid DNA Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.16.4 VGXI Viral Vectors and Plasmid DNA Manufacturing Product Portfolio
- 6.16.5 VGXI Recent Developments
- 6.17 PlasmidFactory
- 6.17.1 PlasmidFactory Company Information
- 6.17.2 PlasmidFactory Business Overview
- 6.17.3 PlasmidFactory Viral Vectors and Plasmid DNA Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.17.4 PlasmidFactory Viral Vectors and Plasmid DNA Manufacturing Product Portfolio
- 6.17.5 PlasmidFactory Recent Developments
7 North America
- 7.1 North America Viral Vectors and Plasmid DNA Manufacturing Market Size (2021-2032)
- 7.2 North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Type
- 7.2.1 North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2021-2026)
- 7.2.2 North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2027-2032)
- 7.2.3 North America Viral Vectors and Plasmid DNA Manufacturing Market Share by Type (2021-2032)
- 7.3 North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Application
- 7.3.1 North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2021-2026)
- 7.3.2 North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2027-2032)
- 7.3.3 North America Viral Vectors and Plasmid DNA Manufacturing Market Share by Application (2021-2032)
- 7.4 North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Country
- 7.4.1 North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2021-2026)
- 7.4.3 North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2027-2032)
- 7.4.4 North America Viral Vectors and Plasmid DNA Manufacturing Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size (2021-2032)
- 8.2 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Type
- 8.2.1 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2021-2026)
- 8.2.2 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2027-2032)
- 8.2.3 Europe Viral Vectors and Plasmid DNA Manufacturing Market Share by Type (2021-2032)
- 8.3 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Application
- 8.3.1 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2021-2026)
- 8.3.2 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2027-2032)
- 8.3.3 Europe Viral Vectors and Plasmid DNA Manufacturing Market Share by Application (2021-2032)
- 8.4 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Country
- 8.4.1 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2021-2026)
- 8.4.3 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2027-2032)
- 8.4.4 Europe Viral Vectors and Plasmid DNA Manufacturing Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Viral Vectors and Plasmid DNA Manufacturing Market Size (2021-2032)
- 9.2 China Viral Vectors and Plasmid DNA Manufacturing Market Size by Type
- 9.2.1 China Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2021-2026)
- 9.2.2 China Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2027-2032)
- 9.2.3 China Viral Vectors and Plasmid DNA Manufacturing Market Share by Type (2021-2032)
- 9.3 China Viral Vectors and Plasmid DNA Manufacturing Market Size by Application
- 9.3.1 China Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2021-2026)
- 9.3.2 China Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2027-2032)
- 9.3.3 China Viral Vectors and Plasmid DNA Manufacturing Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Viral Vectors and Plasmid DNA Manufacturing Market Size (2021-2032)
- 10.2 Asia Viral Vectors and Plasmid DNA Manufacturing Market Size by Type
- 10.2.1 Asia Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2021-2026)
- 10.2.2 Asia Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2027-2032)
- 10.2.3 Asia Viral Vectors and Plasmid DNA Manufacturing Market Share by Type (2021-2032)
- 10.3 Asia Viral Vectors and Plasmid DNA Manufacturing Market Size by Application
- 10.3.1 Asia Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2021-2026)
- 10.3.2 Asia Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2027-2032)
- 10.3.3 Asia Viral Vectors and Plasmid DNA Manufacturing Market Share by Application (2021-2032)
- 10.4 Asia Viral Vectors and Plasmid DNA Manufacturing Market Size by Country
- 10.4.1 Asia Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2021-2026)
- 10.4.3 Asia Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2027-2032)
- 10.4.4 Asia Viral Vectors and Plasmid DNA Manufacturing Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size by Type
- 11.2.1 South America, Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size by Application
- 11.3.1 South America, Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size by Country
- 11.4.1 South America, Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$3,950USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst